• Mechanism of Action: Emedastine is a relatively selective, histamine H1 antagonist.
• Dosage: one drop in the affected eye up to four times daily

Emadine (emedastine difumarate ophthalmic solution) 0.05% is an H1-receptor antagonist indicated for the temporary relief of the signs and symptoms of allergic conjunctivitis.

Yes

Not specified

Emedastine difumarate

Topical

Prescription

0.05%

• Mechanism of Action: Olopatadine is a relatively selective histamine H1 antagonist and an inhibitor of the release of histamine from the mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated. Olopatadine is devoid of effects on alpha-adrenergic, dopaminergic, and muscarinic type 1 and 2 receptors.
• Dosage: One drop in the affected eye(s) once daily

Pataday (olopatadine hydrochloride ophthalmic solution) 0.2% is a histamine H1 antagonist and an inhibitor of the release of histamine from the mast cells indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Yes

Not specified

Olopatadine hydrochloride

Topical

Prescription

0.2%

• Mechanism of Action: Olopatadine is a relatively selective histamine H1 antagonist and an inhibitor of the release of histamine from the mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated. Olopatadine is devoid of effects on alpha-adrenergic, dopaminergic, and muscarinic type 1 and 2 receptors.
• Dosage: One drop in the affected eye(s) once daily

Patanol (olopatadine hydrochloride ophthalmic solution) 0.1% is a histamine H1 antagonist and an inhibitor of the release of histamine from the mast cells indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Yes

Not specified

Olopatadine hydrochloride

Topical

Prescription

0.1%

• Mechanism of Action: Olopatadine is a mast cell stabilizer and a histamine H1 antagonist. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
• Dosage: One drop in the affected eye(s) once daily

Pazeo (olopatadine hydrochloride ophthalmic solution) 0.7% is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis.

Yes

Not specified

Olopatadine hydrochloride

Topical

Prescription

0.7%

• Mechanism of Action: Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis. Ketorolac tromethamine given systemically does not cause pupil constriction
• Dosage: One drop four times a day in the operated eye as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery

Acular LS (ketorolac tromethamine ophthalmic solution) 0.4% is a member of the pyrrolopyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use. It is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

Yes

Not specified

Ketorolac tromethamine

Topical

Prescription

0.4%

• Mechanism of Action: Epinastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell.
• Dosage: One drop in each eye twice daily

Elestat (epinastine HCl ophthalmic solution) 0.05% an antihistamine and an inhibitor of histamine release from the mast cell indicated for the prevention of itching associated with allergic conjunctivitis.

Yes

Not specified

Epinastine HCl

Topical

Prescription

0.05%

• Mechanism of Action: Alcaftadine is a H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
• Dosage: One drop in each eye once daily

Lastacaft (alcaftadine ophthalmic solution) is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

Yes

Not specified

Alcaftadine

Topical

Prescription

0.25%

• Mechanism of Action: Not specified
• Dosage: One drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day

Alaway (ketotifen fumarate ophthalmic solution 0.035%) is an antihistime containing a 0.025% concentration of ketotifen which is equivalent to ketotifen fumarate 0.035%. It is for the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.

Yes

Not specified

Ketotifen fumarate

Topical

Over-the-counter

EQ 0.025% BASE

• Mechanism of Action: Not specified
• Dosage: One drop in the affected eye(s) four times daily

Alrex (loteprednol etabonate ophthalmic suspension 0.2%) is an antiinflammatory corticosteroid indicated for the temporary relief if the signs and symptoms of allergic conjunctivitis.

Yes

Not specified

Loteprednol etabonate

Topical

Prescription

0.2%

• Mechanism of Action: Bepotastine is a topically active, direct H1? receptor antagonist and an inhibitor of the release of histamine from mast cells.
• Dosage: One drop into the affected eye(s) twice aday

Bepreve (bepotastine besilate ophthalmic solution) 1.5% is a histamine H1 receptor antagonist indicated for the treatment of itching associated with allergic conjunctivitis.

Yes

Not specified

Bepotastine besilate

Topical

Prescription

1.5%